NASDAQ:DMAC | Free Cash Flow | DiaMedica Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$9.08M$8,000.00-$9.09M
2025-12-31-$7.77M$6,000.00-$7.77M
2025-03-31-$7.15M$12,000.00-$7.16M
2024-12-31-$6.43M$7,000.00-$6.44M
2024-03-31-$6.65M$9,000.00-$6.66M
2023-12-31-$3.81M$3,000.00-$3.82M
2023-03-31-$5.09M$7,000.00-$5.1M
2022-12-31-$2.77M$32,000.00-$2.8M
2022-03-31-$3.89M$0.00-$3.89M
2021-12-31-$2.8M$7,000.00-$2.81M
2021-03-31-$4.31M$9,000.00-$4.32M
2020-12-31-$3.02M$45,000.00-$3.06M
2020-03-31-$2.98M$2,000.00-$2.98M
2019-12-31-$1.87M
2019-03-31-$3.13M
2018-12-31-$1.9M-$13,000.00-$1.91M
2018-03-31-$935,000.00$32,000.00-$967,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$29.06M$40,000.00-$29.1M
2024-12-31-$22.08M$25,000.00-$22.1M
2023-12-31-$18.73M$24,000.00-$18.75M
2022-12-31-$11.51M$81,000.00-$11.59M
2021-12-31-$12.25M$22,000.00-$12.27M
2020-12-31-$9.19M$47,000.00-$9.23M
2019-12-31-$9.1M$2,000.00-$9.1M
2018-12-31-$5.7M$50,000.00-$5.75M
2017-12-31-$3.9M$22,000.00-$3.92M